Perception of risk from tobacco use is lower among cancer survivors who smoke
the ONA take:
A new study identified several factors that inhibit the efforts of cancer survivors who smoke to quit. In the study, cancer survivors who smoke reported fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who quit before or after their diagnosis.
The researchers report that patients with cancers strongly linked to smoking, such as lung and head and neck, had high initial quit rates; however, many relapse and begin smoking again. Quit rates are not high among patients with other cancers. Researchers feel they may not realize the connection between their cancer and smoking, or they did not receive advice or follow-up assistance in regard to smoking cessation.
The analysis also revealed that survivors who currently smoked reported more daily exposure to others who smoke. The researchers say this is a factor that needs to be considered when counseling patients about quitting smoking. They suggest that exposure to other smokers should be addressed when counseling patients with cancer to quit.
A new study identified several factors that inhibit the efforts of cancer survivors who smoke to quit.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|